Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Injection duration and fentanyl-induced cough
IRCT20200108046052N2Phase 3Completed
- Sponsor
- Hormozgan University of Medical Sciences
- Start
- Feb 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of fentanyl (3 arms), sponsored by Hormozgan University of Medical Sciences. Primary endpoints: Incidence of cough during anesthesia induction and Severity of cough during anesthesia induction. Started Feb 2020; status: completed.
02
Drugs
fentanyl
Beyond the preview
Go deeper on IRCT20200108046052N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200108046052N2.